| Literature DB >> 32542048 |
Joowon Lee1, Maura E Walker1, Kelley P Gabriel2, Ramachandran S Vasan1,3,4, Vanessa Xanthakis1,4,5.
Abstract
BACKGROUND: Few studies examined the individual and conjoint associations of accelerometer-measured physical activity (PA) and sedentary times with the prevalence of chronic kidney disease (CKD) among older adults.Entities:
Mesh:
Year: 2020 PMID: 32542048 PMCID: PMC7295223 DOI: 10.1371/journal.pone.0234825
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of study sample.
| Variables | Men (n = 586) | Women (n = 682) |
|---|---|---|
| Age (years) | 69±8 | 69±7 |
| BMI (kg/m2) | 28.5±4.2 | 27.1±5.2 |
| Total cholesterol (mg/dL) | 172±34 | 198±36 |
| HDL-C (mg/dL) | 55±15 | 69±18 |
| LDL-C (mg/dL) | 94±29 | 106±32 |
| Triglycerides (mg/dL) | 109±54 | 110±52 |
| Use of lipid lowering medications (n, %) | 315 (53.8) | 284 (41.6) |
| SBP (mm Hg) | 127±15 | 125±16 |
| DBP (mm Hg) | 74±9 | 71±9 |
| Hypertension (n, %) | 362 (61.8) | 368 (54.0) |
| Use of antihypertensive medications (n, %) | 325 (55.5) | 311 (45.6) |
| Fasting glucose (mg/dL) | 106±23 | 98±15 |
| Diabetes (n, %) | 88 (15.0) | 54 (7.9) |
| Current Smoking (n, %) | 20 (3.4) | 47 (6.9) |
| eGFR <60 ml/min/1.73m2 (n, %) | 98 (16.7) | 96 (14.1) |
| UACR ≥25/35 μg/mg (men/women) (n, %) | 59 (10.1) | 34 (5.0) |
| Presence of CVD (n, %) | 100 (17.1) | 63 (9.2) |
| Presence of CKD (n, %) | 138 (23.6) | 120 (17.6) |
| Accelerometer Wear Time (min/day) | 791.6±77.9 | 788.0±73.3 |
| Total PA (min/day) | 131.6±59.5 | 113.0±50.9 |
| LIPA (median [25th, 75th percentile], min/day) | 107.3 (78.8, 136.5) | 95.2 (70.0, 120.4) |
| MVPA (median [25th, 75th percentile], min/day) | 14.1 (6.0, 28.5) | 8.9 (2.5, 20.8) |
| Sedentary Time (median [25th, 75th percentile], min/day) | 658.4 (612.5, 705.4) | 668.8 (628.3, 718.1) |
| Adherence to PA Guidelines (≥150 min/week, %) | 214 (36.5) | 164 (24.1) |
Abbreviations: BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; UACR, urine albumin to creatinine ratio; CVD, cardiovascular disease; CKD, chronic kidney disease; PA, physical activity, LIPA, light intensity physical activity; MVPA, moderate to vigorous physical activity.
CVD includes fatal or nonfatal myocardial infarction, unstable angina (prolonged ischemic episode with documented reversible ST-segment changes), peripheral vascular disease (intermittent claudication), cerebrovascular disease (ischemic or hemorrhagic stroke or transient ischemic attack), or heart failure; Values are mean±SD unless otherwise indicated.
Individual associations between objectively measured physical activity and prevalence of CKD.
| Model 1 | Model 2 | Model 3 | ||||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | |||
| Total PA (per 30 min/day increase) | 0.71 (0.64–0.77) | < .001 | 0.82 (0.74–0.92) | < .001 | 0.86 (0.78–0.96) | .007 | ||
| MVPA (per 10 min/day increase) | 0.76 (0.69–0.84) | < .001 | 0.87 (0.79–0.96) | .005 | 0.92 (0.84–1.01) | .07 | ||
| PA Guideline (MVPA ≥150 min/week or not) | 0.50 (0.36–0.70) | < .001 | 0.71 (0.50–1.03) | .07 | 0.89 (0.60–1.31) | .55 | ||
| LIPA (per 30 min/day increase) | 0.68 (0.61–0.76) | < .001 | 0.83 (0.73–0.94) | .004 | 0.87 (0.76–0.99) | .03 | ||
| Sedentary time (per 30 min/day increase) | 1.04 (0.99–1.10) | .14 | 1.22 (1.09–1.35) | < .001 | 1.16 (1.04–1.29) | .007 | ||
Abbreviations: CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval; PA, physical activity; MVPA, moderate to vigorous physical activity; LIPA, light intensity physical activity.
Model 1 is unadjusted; Model 2 adjusted for age, sex, and accelerometer wear time; Model 3 adjusted for age, sex, accelerometer wear time, smoking, BMI, SBP, use of antihypertensive medication, diabetes, TC/HDL-C, use of lipid-lowering medication, and the prevalence of CVD at exam 9; All PA variables and sedentary time were considered as exposure variables (separate model for each); CVD includes fatal or nonfatal myocardial infarction, unstable angina (prolonged ischemic episode with documented reversible ST-segment changes), peripheral vascular disease (intermittent claudication), cerebrovascular disease (ischemic or hemorrhagic stroke or transient ischemic attack), or heart failure.
Compositional variation matrix of time spent in individual activity behaviors.
| LIPA | MVPA | |
|---|---|---|
| Sedentary | 0.24 | 2.31 |
| LIPA | - | 1.69 |
| MVPA | - | - |
Abbreviations: LIPA, light intensity physical activity; MVPA, moderate to vigorous physical activity.
Values closer to zero indicate that the proportion of time in the two physical activity behaviors included in the ratio was highly co-dependent.
Predicted differences in eGFR (ml/min/1.73m2) and UACR (μg/mg) following reallocation of physical activity time.
| Sedentary time | LIPA | MVPA | |
| Sedentary time (1%) | - | 0.16 | 0.06 |
| LIPA (1%) | -0.18 | - | -0.12 |
| MVPA (1%) | -0.13 | 0.03 | - |
| Sedentary time (5%) | - | 0.73 | 0.21 |
| LIPA (5%) | -1.06 | - | -0.86 |
| Sedentary time | LIPA | MVPA | |
| Sedentary time (1%) | - | -2.23 | -4.82 |
| LIPA (1%) | 2.39 | - | -2.43 |
| MVPA (1%) | 14.37 | 12.14 | - |
| Sedentary time (5%) | - | -10.27 | -13.85 |
| LIPA (5%) | 14.27 | - | 0.53 |
Abbreviations: eGFR, estimated glomerular filtration rate; UACR, urine albumin to creatinine ratio; LIPA, light intensity physical activity; MVPA, moderate to vigorous physical activity.
Reallocation of proportions of time from the physical activity behaviors in rows to physical activity behaviors in columns; For example, 0.16 ml/min/1.73m2 increase from the mean eGFR if 1% of sedentary time is replaced by 1% of LIPA; All compositional activity behaviors (Sedentary time, LIPA, and MVPA expressed as individual isometric log-ratio co-ordinates) were significantly associated (P <0.05) with eGFR and UACR.